Suppr超能文献

血管内腹主动脉瘤修复术中高剂量腺苷诱发心脏停搏的安全性与有效性

Safety and efficacy of high-dose adenosine-induced asystole during endovascular AAA repair.

作者信息

Kahn R A, Moskowitz D M, Marin M L, Hollier L H, Parsons R, Teodorescu V, McLaughlin M

机构信息

Department of Anesthesiology, The Mount Sinai-New York University Medical Center, New York 10029, USA.

出版信息

J Endovasc Ther. 2000 Aug;7(4):292-6. doi: 10.1177/152660280000700406.

Abstract

PURPOSE

To assess the safety and efficacy of high-dose adenosine administration to increase the precision of endovascular abdominal aortic aneurysm (AAA) repair using a balloon deployed stent-graft.

METHODS

From January 1997 to March 1999, 98 AAA patients (79 men; mean age 71 years, range 62-91) were treated with balloon-expandable stent-grafts under an approved protocol. After placing a temporary transvenous ventricular lead or an external transthoracic pacing electrode, adenosine (24 mg initially) was administered in an escalating dose fashion to induce at least 10 seconds of asystole, during which the proximal stent was expanded.

RESULTS

Adenosine dosages ranged from 24 to 90 mg (median 24 mg). Nine (9.2%) self-limiting cardiac events were observed: 2 (2.0%) episodes of transient myocardial ischemia, 2 (2.0%) cases of atrial fibrillation requiring cardioversion, 1 (1.0%) transient left bundle branch block lasting <10 seconds, and 4 (4.1%) prolonged periods of asystole requiring temporary pacemaker activation. There were no cases of bronchospasm or worsening obstructive pulmonary disease, and no patients required inotropic support after adenosine-induced asystole.

CONCLUSIONS

Cardiac events following adenosine-induced asystole are infrequent, mild, and easily treated. The perioperative use of high-dose adenosine to ensure precise stent-graft placement appears to be a safe method of inducing temporary asystole during endovascular aortic repair.

摘要

目的

评估大剂量腺苷给药的安全性和有效性,以提高使用球囊扩张式覆膜支架进行血管内腹主动脉瘤(AAA)修复的精确性。

方法

1997年1月至1999年3月,98例AAA患者(79例男性;平均年龄71岁,范围62 - 91岁)按照批准的方案接受球囊扩张式覆膜支架治疗。放置临时经静脉心室导联或体外经胸起搏电极后,以递增剂量方式给予腺苷(初始剂量24 mg),以诱导至少10秒的心脏停搏,在此期间扩张近端支架。

结果

腺苷剂量范围为24至90 mg(中位数24 mg)。观察到9例(9.2%)自限性心脏事件:2例(2.0%)短暂性心肌缺血发作,2例(2.0%)需要心脏复律的心房颤动病例,1例(1.0%)持续时间<10秒的短暂性左束支传导阻滞,以及4例(4.1%)需要临时起搏器激活的心脏停搏延长病例。没有支气管痉挛或阻塞性肺疾病恶化的病例,腺苷诱导心脏停搏后也没有患者需要使用正性肌力药物支持。

结论

腺苷诱导心脏停搏后的心脏事件发生率低、症状轻微且易于治疗。围手术期使用大剂量腺苷以确保精确放置覆膜支架似乎是血管内主动脉修复期间诱导临时心脏停搏的一种安全方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验